Neuros Co., Ltd. (KOSDAQ:A126870) announced a private placement of series fifth unregistered coupon unguaranteed private convertible bonds for gross proceeds of KRW 10,000,000,000 and sixth series registered coupon unguaranteed private convertible bonds for gross proceeds of KRW 10,000,000,000 for aggregate gross proceeds of KRW 20,000,000,000 on February 23, 2018. The fifth series bonds will include participation from Golden Bridge Asset Management Co., Ltd. for KRW 2,400,000,000, Synergy Asset Management Co., Ltd. for KRW 4,800,000,000, Synergy- Hanhwa Mezzanine No. 1 New Technology Investment Fund for KRW 250,000,000, Synergy- Hanhwa Mezzanine No. 2 New Technology Investment Fund for KRW 250,000,000, Synergy- Hanhwa Mezzanine No. 3 New Technology Investment Fund for KRW 300,000,000, Synergy- Hanhwa Mezzanine No. 4 New Technology Investment Fund for KRW 200,000,000, Synergy- Hanhwa Mezzanine No. 5 New Technology Investment Fund for KRW 100,000,000, Synergy- Hanhwa Mezzanine No. 6 New Technology Investment Fund for KRW 100,000,000, Synergy- Hanhwa Mezzanine No. 7 New Technology Investment Fund for KRW 100,000,000, and Synergy-Shinhan Mezzanine New Technology Investment Fund for KRW 1,500,000,000. The bonds do not carry any interest rate. The bonds have a yield to maturity of 2% per annum. The bonds are issued at par and have a maturity date on February 27, 2021. The bonds are 100% convertible into 1,199,040 common shares at a price of KRW 8,340 per share. The conversion period is from February 27, 2019 to January 27, 2021. The transaction is expected to close on February 27, 2018. The bonds issued cannot be exercised or converted for the period of one year from the date of issuance. The transaction has been approved by the board of directors of the company. On February 26, 2018, the company announced that the bonds will be convertible into 1,199,904 common shares at a price of KRW 8,334 per share.